ScholarIQanswers from OpenAlex
Bevacizumab for the treatment of a complicated posterior melanocytoma
PaperCitations, authors & open-access status
Bevacizumab for the treatment of a complicated posterior melanocytoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bevacizumab for the treatment of a complicated posterior melanocytoma have?
ScholarIQcitation count
Bevacizumab for the treatment of a complicated posterior melanocytoma has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Bevacizumab for the treatment of a complicated posterior melanocytoma published?
ScholarIQyear
Bevacizumab for the treatment of a complicated posterior melanocytoma has 2015 year in the ScholarIQ index.
What is the open-access status of Bevacizumab for the treatment of a complicated posterior melanocytoma?
ScholarIQoa status
Bevacizumab for the treatment of a complicated posterior melanocytoma has green oa status in the ScholarIQ index.
What is the OpenAlex record for Bevacizumab for the treatment of a complicated posterior melanocytoma?
ScholarIQopenalex
The OpenAlex for Bevacizumab for the treatment of a complicated posterior melanocytoma is on the source record.